Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10040428 | 0.91 | DPP8 (0.34) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL10259411 | 0.89 | DPP8 (0.37) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL15396578 | 0.86 | EPHX2 (0.34) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL10040425 | 0.86 | CYP19A1 (0.36) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL13563630 | 0.85 | DPP8 (0.33) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL13563631 | 0.85 | DPP8 (0.33) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL14183864 | 0.84 | CYP17A1 (0.34) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL10040432 | 0.84 | ALDH1A1 (0.36) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL9944511 | 0.84 | DPP8 (0.39) | DPP8DPP9DPP4CYP17A1CYP19A1 | |
| SCHEMBL10040426 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8703408-B2 | Patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-04-22 | — | — | US | disclosed |
| US-8440386-B2 | Patterning process, resist composition, and acetal compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-05-14 | — | — | US | disclosed |
| US-20120009527-A1 | PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-01-12 | — | — | US | disclosed |
| US-20110236826-A1 | PATTERNING PROCESS, RESIST COMPOSITION, AND ACETAL COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110236826-A1 | PATTERNING PROCESS, RESIST COMPOSITION, AND ACETAL COMPOUND | PARG, RAD51, CD38 | DPP8 4872/4885DPP9 4799/4885DPP4 4847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.